Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Compounded tirzepatide is a formulation of tirzepatide — a medication for type 2 diabetes and weight loss. Tirzepatide is the ...

Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...

Illinois AG warns against misleading GLP-1 drug sales, urging consumers to only buy from reliable sources and use ...

Americans are getting slimmer. The rise of GLP-1 medications has transformed the way Americans lose weight, and the data supports that: ...

popular diabetes and weight-loss drugs Mounjaro and Zepbound — is officially over. The news could put pressure on companies that have been able to sell off-brand versions of GLP-1 weight-loss ...

Here are five updates on this industry: 1. Weight loss results Eli Lilly's obesity drug Zepbound — which saw a 300% increase in prescription fills throughout 2024 — led to higher weight loss ...